1 / 11

Global Antibody Drug Conjugates Market to be Worth US$11,062.460 million by 2024

<br>The global antibody-drug conjugates (ADCs) market is expected to reach US$11,062.460 million by 2024 from US$2,704.460 million in 2018, at a CAGR of 26.46%.The market is segmented by Target, by Indication, and by geography with country level analysis

jainvipin1233
Télécharger la présentation

Global Antibody Drug Conjugates Market to be Worth US$11,062.460 million by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antibody Drug Conjugates Market  Forecast From 2019 to 2024

  2. DESCRIPTION The global antibody-drug conjugates (ADCs) market is expected to reach US$11,062.460 million by 2024 from US$2,704.460 million in 2018, at a CAGR of 26.46%. Antibody-drug conjugates consist of a monoclonal antibody (mAb), a cytotoxic drug and a linker. These ADCs help in providing selectivity where it is able to select a tumor from a normal cell, hence provides effective therapy for targeted cancer treatment, promoting the market growth during the forecast period.

  3. Key Questions Answered By The Report • What will be Antibody Drug Conjugates Market from 2019 to 2024? • How are the major drivers and restraints affecting the Antibody Drug Conjugates Market. • growth and the opportunities which exist for key vendors? • Which segment and region will drive or lead the market growth and why? • A comprehensive analysis of competitive landscape and key market participant’s behavior • Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth

  4. Segments Covered Antibody Drug Conjugates Market are : • By Target • CD 30 • CD 22 • HER 2 • By Indication • Haematologic Malignancies • Non-Haematologic Malignancies

  5. Geography • North America • United States • Canada • Mexico • Others • South America • Brazil • Argentina • Others

  6. Geography Europe • Germany • France • Italy • United Kingdom • Others Middle East and Africa • Israel • Saudi Arabia • UAE • Others Asia Pacific • Japan • China • India • Others

  7. COMPANY PROFILES Takeda Pharmaceutical Company Limited F. Hoffmann-La Roche Ltd. ImmunoGen Inc. Pfizer Inc. Lonza Synthon Holding B.V. Immunomedics Biotest AG Astellas Pharma Inc. Seattle Genetics, Inc.

  8. TO ORDER OR REQUEST FOR A SAMPLE: Antibody Drug Conjugates Market– Forecasts from 2019 to 2024 Link : https://www.knowledge-sourcing.com/report/global-antibody-drug-conjugates-market Price: US$3,230 – Single User License US$3,740 – Multi User License US$5,780 – Enterprise License Payment:  To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with payment.  For wire transfer, write to us at sales@knowledge-sourcing.com  For any custom requirements or queries, please visit our website or call us:  Website: www.knowledge-sourcing.com Phone: +1-850-250-1698

  9. Contact Us Address Knowledge Sourcing Intelligence LLPSuite 406, BSI Business ParkH-140, Sector 63 Noida, U.P. - 201301India Phone: +1-850-250-1698 Email info@knowledge-sourcing.com Visit us : https://www.knowledge-sourcing.com

  10. Follow Us: Press Releases and Blogs: Click Here…

  11. THANK YOU

More Related